| Liver transplant associated with paracetamol overdose: results from the seven‐country SALT study SE Gulmez, D Larrey, GP Pageaux, J Bernuau, F Bissoli, Y Horsmans, ... British Journal of Clinical Pharmacology 80 (3), 599-606, 2015 | 97 | 2015 |
| Using data mining techniques to explore physicians' therapeutic decisions when clinical guidelines do not provide recommendations: methods and example for type 2 diabetes M Toussi, JB Lamy, P Le Toumelin, A Venot BMC medical informatics and decision making 9, 1-12, 2009 | 87 | 2009 |
| Costs of perennial allergic rhinitis and allergic asthma increase with severity and poor disease control M Belhassen, P Demoly, E Bloch‐Morot, G De Pouvourville, M Ginoux, ... Allergy 72 (6), 948-958, 2017 | 46 | 2017 |
| HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: a good practices report of a joint ISPE/ISPOR … SV Wang, A Pottegård, W Crown, P Arlett, DM Ashcroft, EI Benchimol, ... Value in Health 25 (10), 1663-1672, 2022 | 44 | 2022 |
| Microvascular outcomes in patients with type 2 diabetes treated with vildagliptin vs. sulfonylurea: a retrospective study using German electronic medical records WM Kolaczynski, M Hankins, SH Ong, H Richter, A Clemens, M Toussi Diabetes Therapy 7, 483-496, 2016 | 35 | 2016 |
| Evaluation of the reported rates of severe hypersensitivity reactions associated with ferric carboxymaltose and iron (III) isomaltoside 1000 in Europe based on data from … B Ehlken, L Nathell, A Gohlke, D Bocuk, M Toussi, S Wohlfeil Drug safety 42, 463-471, 2019 | 33 | 2019 |
| Glucose lowering therapeutic strategies for type 2 diabetic patients with chronic kidney disease in primary care setting in france: a cross-sectional study N Grandfils, B Detournay, C Attali, D Joly, D Simon, B Vergès, M Toussi, ... International Journal of Endocrinology 2013, 2013 | 26 | 2013 |
| A novel method for measuring patients' adherence to insulin dosing guidelines: introducing indicators of adherence M Toussi, C Choleau, G Reach, M Cahané, A Bar-Hen, A Venot BMC Medical Informatics and Decision Making 8, 1-9, 2008 | 20 | 2008 |
| Effectiveness of risk minimisation measures for valproate: a drug utilisation study in Europe M Toussi, M Shlaen, F Coste, H de Voogd, V Dimos, S Kaplan Pharmacoepidemiology and Drug Safety 30 (3), 292-303, 2021 | 15 | 2021 |
| Representing the patient's therapeutic history in medical records and in guideline recommendations for chronic diseases using a unique model V Ebrahiminia, C Duclos, ME Toussi, C Riou, R Cohen, A Venot Studies in Health Technology and Informatics 116, 101-106, 2005 | 13 | 2005 |
| Overview of the European post‐authorisation study register post‐authorization studies performed in Europe from September 2010 to December 2018 J Sultana, S Crisafulli, M Almas, IC Antonazzo, E Baan, C Bartolini, ... Pharmacoepidemiology and Drug Safety 31 (6), 689-705, 2022 | 8 | 2022 |
| Evaluation of the effectiveness of risk minimization measures for trimetazidine: a cross sectional joint PASS survey among physicians in selected European countries D von Bredow, M Toussi, A Samad, S Kaplan, M Domahidy, H de Voogd, ... Pharmacoepidemiology and Drug Safety 27 (12), 1385-1392, 2018 | 7 | 2018 |
| An automated method for analyzing adherence to therapeutic guidelines: Application in diabetes. M Toussi, V Ebrahiminia, P Le Toumelin, R Cohen, A Venot Studies in Health Technology and Informatics 136, 339, 2008 | 7 | 2008 |
| Effectiveness of risk minimisation measures for valproate: A cross‐sectional survey among physicians in Europe M Toussi, B Isabelle, S Tcherny‐Lessenot, H de Voogd, V Dimos, ... Pharmacoepidemiology and Drug Safety 30 (3), 283-291, 2021 | 6 | 2021 |
| Safety and persistence of nalmefene treatment for alcohol dependence. Results from Two Post-authorisation Safety Studies J Chick, F Andersohn, S Guillo, K Borchert, M Toussi, S Braun, JS Haas, ... Alcohol and Alcoholism 56 (5), 556-564, 2021 | 5 | 2021 |
| Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group MA Hogervorst, R Vreman, I Heikkinen, I Bagchi, I Gutierrez-Ibarluzea, ... International journal of technology assessment in health care 39 (1), e40, 2023 | 4 | 2023 |
| Effectiveness of risk minimization measures for valproate: a drug utilization study based on implementation of a risk minimization programme in Europe, analysis of data from the UK B Ehlken, C Nishikawa, S Kaplan, I Dresco, D Granados, M Toussi Current Medical Research and Opinion 38 (3), 461-468, 2022 | 2 | 2022 |
| Real world utilization of 91 day extended levonorgestrel-containing combined oral contraceptives in Europe: a multinational database study S Kaplan, M Toussi, A Evans, S Dhanda, D Roy, A Lass Current Medical Research and Opinion 37 (3), 515-522, 2021 | 2 | 2021 |
| Evaluation of the effectiveness of risk minimisation measures targeting physicians on prescribing practices of Thiocolchicoside containing medicinal products for systemic use SL Jouaville, C Ehrhardt, ML Kurzinger, H de Voogd, M Toussi PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 28, 466-466, 2019 | 2 | 2019 |
| Evaluation of the Effectiveness of Risk Minimisation Measures: A Survey Among Health Care Professionals to Assess Their Knowledge and Attitudes on Prescribing Conditions of … M Toussi, I Bardoulat, A Garofano PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 26, 428-428, 2017 | 2 | 2017 |
